Sustainability | December 12, 2025
Dr. Reddy's Laboratories announces SBTi targets
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
Zyrifa is indicated for patients with bone metastases stemming from a wide range of solid tumors
The agreement allows Biocon Biologics to commercialize both its Denosumab biosimilars (Vevzuo and Evfraxy) in Europe starting December 2, 2025
FDA's withholding of the PRV was contrary to law because no drug product containing phenobarbital sodium was 'previously approved'
This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
Most recently, Yuvraj was the Director of Operations, Business Development & Process Excellence at Zeon Lifesciences Ltd
RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
The partnership will enable rapid and reliable product delivery
Glucagon-Like Peptide-1 is a natural hormone that regulates blood sugar, controls appetite, and slows digestion
Subscribe To Our Newsletter & Stay Updated
